ONC-392 for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where ONC-392 was used for Malignant melanoma.
Most Reported Side Effects for ONC-392
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Immune-mediated enterocolitis | 8 | 29.6% | 1 | 8 |
Other Indications for ONC-392
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)